HMG-CoA Reductase Inhibitor Therapy and Peripheral Neuropathy
Ann Int Med 120:970, Jacobs,M.B., 1994
Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab
J Immunother Cancer 6:11, Cafuir, L.,et al, 2018
Oral Fluoroquinolone Use and Risk of Peripheral Neuropathy
Neurol 83:1261-1263, Etminan, M.,et al, 2014
Progressive Weakness with Respiratory Failure in a Patient with Sarcoidosis
Arch Neurol 69:534-537, Chaudhry,P.,et al, 2012
Longitudinal Assessment of Oxaliplatin-Induced Neuropathy
Neurol 77:980-986, Burakgazi, A.Z.,et al, 2011
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Painful Peripheral Neuropathy Associated with Voriconazole Use
Arch Neurol 62:144-146, Tsiodras,S.,et al, 2005
Peripheral Neuropathy
Lancet 363:2151-2161, England,J.D. &Asbury,A.K., 2004
Thalidomide Sensory Neurotoxicity
Neurol 62:2291-2293, Cavaletti,G.,et al, 2004
Disopyramide-induced Neuropathy
Neurol 58:663, Briani,C.,et al, 2002
Thalidomide-Induced Neuropathy
Neurol 59:1872-1875, Chaudhry,V.,et al, 2002
Amantadine-Induced Peripheral Neuropathy
Neurol 53:1862-1865, Shulman,L.M.,et al, 1999
2', 3'-Dideoxycytidine (ddC) Toxic Neuropathy:A Study of 52 Patients
Neurol 43:358-362, Berger,A.R.,et al, 1993
Therapy for Human Immunodeficiency Virus Infection
NEJM 328:1686-1695, Hirsch,M.S.&D'Aquila,R., 1993
Peripheral Neuropathy in a Patient Receiving Enalapril
Editorial, BMJ 305:13321992., , 1992
Acute Sensory Neuropathy-Neuronopathy from Pyridoxine Overdose
Neurol 37:1729-1732, Albin,R.L.,et al, 1987
Treatment of Peripheral Neuropathies
JNNP 48:1193-1207, Hallett,M.,et al, 1985
The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984
Drug-Induced Peripheral Neuropathies
BMJ 1:663-666, Argov,Z.&Mastaglia,F.L., 1979